Zelanna Goldberg

Dr. Zelanna Goldberg, the Chief Medical Officer at Replicate Bioscience, is a radiation oncologist with over 20 years’ experience in drug development and industry leadership. Before joining Replicate, she was Chief Medical Officer at Alpine Immune Sciences and, before Alpine, she was Senior Vice President of Clinical Development at Iovance Biotherapeutics, where she led development programs in non small-cell lung cancers, head and neck cancers, and combination strategies. Prior to Iovance, she spent nearly nine years at Pfizer, where she held positions of increasing responsibility in global clinical development and worked on three successful global registrational studies. Dr. Goldberg co-developed the clinical materials for the Master of Science in Drug Development Program at the University of California San Diego (UCSD), and before joining industry, she was an associate professor at the University of California Davis.

Dr. Goldberg earned her M.D. from the University of Toronto, where she completed her residency in radiation oncology, and a master’s degree in Healthcare Organization Leadership from UCSD. She is an inventor on multiple patents.